Strategic Partners A/S (CPH:STRAP)
Denmark · Delayed Price · Currency is DKK 620.00
-50.00 (-7.46%)
May 13, 2026, 4:59 PM CET
Strategic Partners Market Cap
Strategic Partners has a market cap or net worth of 25.86 million as of May 14, 2026. Its market cap has decreased by -23.47% in one year.
Market Cap
25.86M
Enterprise Value
9.94M
Revenue
309.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
620.00
Market Cap Chart
Since November 21, 2017, Strategic Partners's market cap has decreased from 1.59B to 25.86M, a decrease of -98.38%. That is a compound annual growth rate of -38.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 25.86M | -11.17% |
| Dec 30, 2025 | 29.11M | -15.40% |
| Dec 30, 2024 | 34.42M | -26.72% |
| Dec 29, 2023 | 46.96M | 51.14% |
| Dec 30, 2022 | 31.07M | -94.82% |
| Dec 30, 2021 | 599.78M | -74.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.33T |
| Genmab | 103.38B |
| Coloplast | 89.91B |
| ALK-Abelló | 56.01B |
| Gubra | 5.32B |
| BioPorto | 599.08M |
| ViroGates | 99.32M |
| Pharma Equity Group | 98.20M |